ArticleFrontiers in public health2025
Early diagnosis and survival outcomes in silicosis: a retrospective cohort study of 11,809 patients in Guangdong Province, China (1956-2020).
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evaluation of Serum Prolidase as a Biomarker and the Effects of Nintedanib in an Experimental Rat Model of Silicosis.Journal of clinical medicine · 2026Article
- Article
- Internal and external silica dust exposure threshold as an early screening index for silicosis: a cross-sectional study.Frontiers in public health · 2025Article
- Survival analysis of pneumoconiosis patients in Jiangsu Province from 1960 to 2024.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Silicosis, a progressive occupational lung disease caused by silica dust exposure, remains a global public health challenge due to limited therapeutic options. Early diagnosis is hypothesized to improve survival outcomes, yet evidence linking diagnostic stage to mortality remains scarce. This study aimed to evaluate the association between early diagnosis and survival in silicosis patients and assess the impact of delayed diagnosis on mortality. Methods: A retrospective cohort study analyzed 11,809 silicosis patients diagnosed between 1956 and 2020 in Guangdong Province, China. Data were extracted from occupational disease registries, multi-sectoral databases, and provincial monitoring systems. Exclusion criteria included ambiguous diagnosis dates, pre-adolescent exposure, and missing variables. Cox proportional hazards models adjusted for covariates (sex, age, region, industry, exposure duration) were used to assess mortality risks across stages I-III. Survival curves, temporal trends, and subgroup analyses were performed. Results: Most patients (77.8%) were diagnosed at stage I, with median survival times declining sharply across stages: 27 years (stage I), 20 years (stage II), and 11 years (stage III) ( Discussion: This study demonstrates that early diagnosis significantly prolongs survival in silicosis patients, with advanced stages correlating with exponentially higher mortality. The findings underscore the urgent need for systematic early screening, such as high-resolution CT, and stricter occupational health policies to reduce silica exposure. Despite limitations, including unmeasured confounders like smoking status, this research provides critical evidence to inform global strategies for mitigating silicosis through timely detection and workplace safety reforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.